Sarah Howell
Chief Executive Officer chez ARECOR THERAPEUTICS PLC
Fortune : 2 M $ au 31/03/2024
Profil
Sarah Jennifer Howell is currently the Chief Executive Officer & Director at Arecor Ltd.
and the Chief Executive Officer & Executive Director at Arecor Therapeutics Plc.
Previously, she held positions as the Director-Outsourced Manufacturing & Biologics at UCB SA, Team Leader at GSK Plc, and VP-Chemistry, Manufacturing & Controls at BTG Ltd.
She obtained an undergraduate degree from the University of Birmingham and a doctorate degree from the University of St. Andrews.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARECOR THERAPEUTICS PLC
2,83% | 16/11/2022 | 867 738 ( 2,83% ) | 2 M $ | 31/03/2024 |
Postes actifs de Sarah Howell
| Sociétés | Poste | Début |
|---|---|---|
| ARECOR THERAPEUTICS PLC | Chief Executive Officer | - |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Chief Executive Officer | 01/01/2015 |
Anciens postes connus de Sarah Howell
| Sociétés | Poste | Fin |
|---|---|---|
| UCB | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
| BTG | Corporate Officer/Principal | - |
Formation de Sarah Howell
| University of Birmingham | Undergraduate Degree |
| University of St. Andrews | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| UCB | Health Technology |
| Entreprise privées | 3 |
|---|---|
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Arecor Therapeutics Plc |
